Physician Assistant

Physician Assistant
Audio Summaries

The literature in physician assistant doesn't slow down, and the papers you skip might be the ones that change your practice. OSLR turns the journals you'd read if you had the time into 3-minute audio summaries. Listen on your commute, between cases, whenever.

8 active journals1,118 audio summaries

Recent summaries

The latest articles summarized from physician assistant journals.

2026-2027 Influenza, RSV, and SARSCoV-2 Immunization Recommendations for Nonpregnant, Immunocompetent Adults and Health Care Personnel.

American family physician|Nov 20, 2026

This AAFP guidance provides annual 2026-2027 immunization recommendations for influenza, RSV, and SARS-CoV-2 in nonpregnant, immunocompetent adults aged 19 and older and in health care personnel. It directs other groups to separate guidance from the AAP (children and adolescents), IDSA (immunocompromised individuals), and ACOG (pregnant individuals), and states that the AAFP recommendation should be followed where guidance differs. The provided abstract does not include the specific vaccine recommendations, so those details would need to be taken from the full article.

Emerging Vector-Borne Diseases in North America.

American family physician|Nov 20, 2026

This review examines emerging vector-borne diseases in North America, asking which mosquito- and tick-borne infections are increasing and what drives their spread. The authors identify viral threats such as West Nile, dengue, chikungunya, and Zika, and bacterial threats including ehrlichiosis, anaplasmosis, and Rocky Mountain spotted fever, which are treated promptly with doxycycline. They attribute rising incidence to climate change, urbanization, and greater human contact with vector habitats, and they recommend protective measures such as clothing, bed nets, DEET or picaridin repellents, and permethrin-treated clothing, applied throughout the day as well as at night.

Elbow Pain in Adults: Evaluation and Differential Diagnosis.

American family physician|Nov 20, 2026

This review addresses how primary care clinicians can evaluate adult elbow pain efficiently, asking how to narrow the differential diagnosis and when to use imaging. The authors propose a regional approach, localizing pain to the anterior, lateral, medial, or posterior elbow, combined with focused physical examination to distinguish soft tissue from intra-articular causes. They also outline red flag features that require urgent evaluation and recommend radiography for suspected fracture or mechanical symptoms, ultrasonography for tendon and nerve assessment, and MRI reserved for persistent or complex cases.

Hyperlipidemia: Pharmacotherapy for Cardiovascular Risk Reduction in Adults.

American family physician|Nov 20, 2026

This review addresses how clinicians should use risk calculators (PREVENT and Pooled Cohort Equations) and lipid-lowering medications to reduce cardiovascular risk in adults with and without established atherosclerotic cardiovascular disease. The authors conclude that statins remain first-line therapy for primary and secondary prevention, with nonstatin agents reserved for statin intolerance or inadequate LDL-C lowering, and that treatment decisions should be individualized through shared decision-making. The article also highlights special considerations for older adults, younger adults with elevated lifetime risk, and patients of childbearing potential.

Gait and Balance Disorders in Older Adults.

American family physician|Nov 20, 2026

This review addresses how primary care physicians can recognize, evaluate, and manage gait and balance disorders that drive falls in older adults. The authors outline common causes (such as arthritis and sarcopenia) and less common ones (such as Parkinson disease, Huntington disease, and normal pressure hydrocephalus), describe screening and fall-risk tools like the Timed Up and Go, 30-Second Chair Stand, and 4-Stage Balance tests, and recommend multifactorial fall-prevention strategies emphasizing physical activity, appropriate assistive devices, and strength training.

Seasonal mass vaccination with R21/Matrix-M against malaria in The Gambia and Burkina Faso: an open-label, cluster-randomised, controlled trial.

Lancet (London, England)|Nov 19, 2026

This cluster-randomised trial asked whether seasonal mass vaccination with the R21/Matrix-M malaria vaccine, given before peak transmission, could reduce malaria infection prevalence and be safe in The Gambia (low-to-moderate transmission) and Burkina Faso (intense seasonal transmission). Across 54 villages, three monthly doses reduced the odds of P. falciparum infection at peak transmission by 70% in The Gambia (aOR 0.30) and by 25% in Burkina Faso (aOR 0.75), with the vaccine judged safe and well tolerated. The authors conclude that seasonal mass vaccination could be an additional malaria control strategy in seasonal transmission settings, though its effect was considerably larger in The Gambia than in Burkina Faso.

Reproductive health in women in Britain from 2010 to 2024: findings from repeated, cross-sectional National Surveys of Sexual Attitudes and Lifestyles (Natsal).

Lancet (London, England)|Nov 19, 2026

This study compares reproductive health indicators among women aged 16-54 in Britain using nationally representative Natsal surveys from 2010-2012 (Natsal-3) and 2022-2024 (Natsal-4), asking whether reproductive autonomy has improved and how it varies across social groups. Key findings include an increase in lifetime abortion (16.0% to 20.7%), a rise in women aged 16-44 reporting they definitely do not want children (7.7% to 16.6%), and a sharp drop in hormonal contraception use among women under 35. Persistent gaps remain: 18.5% of women at risk of unintended pregnancy reported no effective contraception, and women with lower education, greater deprivation, or Black African/Caribbean/Black British ethnicity faced higher risks of no effective contraception and abortion.

Spontaneous coronary artery dissection: implications for women's health, clinical care, and future research.

Lancet (London, England)|Nov 19, 2026

Spontaneous coronary artery dissection (SCAD) is an increasingly recognized cause of acute coronary syndromes, mainly affecting younger women, and is likely more common than previously thought. This Review synthesizes current evidence on SCAD's epidemiology, mechanisms (including genetic susceptibility), diagnosis, management, and implications for reproductive and women's health. It also identifies research priorities, since evidence guiding pharmacological and interventional treatment remains scarce, even though most patients heal spontaneously and are best managed conservatively.

Plasma eMTBR-tau as a Biomarker for Chronic Traumatic Encephalopathy Tau Tangle Neuropathology.

JAMA|Nov 19, 2026

This case series of 21 former American football players examined whether plasma endogenously cleaved microtubule-binding region tau (eMTBR-tau) could serve as an in vivo biomarker for chronic traumatic encephalopathy (CTE) tau tangle pathology, which currently can only be confirmed at autopsy. Plasma eMTBR-tau was significantly higher in CTE-positive donors than CTE-negative donors, and highest in high-stage CTE with comorbid Alzheimer disease neuropathologic change, with levels also correlating with neuropathologic tau burden. The authors conclude that plasma eMTBR-tau may be a feasible candidate biomarker for high-stage CTE, though larger validation studies are needed to establish diagnostic accuracy and specificity.

Assessing Multiple Treatment Regimens for Tuberculosis.

The New England journal of medicine|Nov 19, 2026

This phase 2 randomized trial (PARADIGM4TB) asked whether new four-drug regimens containing ganfeborole and/or BTZ-043 could shorten or improve tuberculosis treatment compared with the standard 24-week HRZE regimen, using early sputum culture clearance (log10 time-to-positivity slope) as the primary measure. Two regimens, ganfeborole-bedaquiline-pretomanid-moxifloxacin (BPMG) and BTZ-043-bedaquiline-delamanid-moxifloxacin (BDMT), showed a posterior probability of superiority over HRZE of 0.83 and 0.99, respectively, with acceptable safety profiles to advance to further evaluation. The results were used to select regimens for further study rather than to establish definitive efficacy.

Start listening to physician assistant research

14-day free trial. Pick your journals and go.